Clinical trial
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the…
NCT00295802 · EDAP TMS S.A., Industry · Unknown status
Key facts
| NCT number | NCT00295802 |
|---|---|
| Title | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer |
| Official title | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer |
| Lead sponsor | EDAP TMS S.A., Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device |
| Interventions | Integrated Imaging High Intensity Focused Ultrasound, Endocare CRYOcare Cryosurgical and Galil Medical CRYO-HIT Systems (cryotherapy) |
| Enrollment | 141 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2012 |
| Completion | Sep 1, 2014 |
| First posted | Feb 24, 2006 |
| Last update posted | Feb 7, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: